DCVC Bio is a venture capital fund that invests in early-stage life science companies driven by deep-tech approaches.
DCVC Bio is a venture capital fund that invests in early-stage life science companies driven by deep-tech approaches. Advances in genetic sequencing, artificial intelligence, and automation are converging to transform existing life sciences technologies and speed the development of new ones. The firm is looking for companies affecting deep technological change in synthetic biology, medicine, and agriculture.DCVC Bio was founded in 2018 and is based in San Francisco, California, United States.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 29, 2022
Verdant Robotics
|
Series A | $46.50M | Agriculture | — |
Oct 13, 2020
MycoWorks
|
Series B | $45M | Advanced Materials | Yes |
Mar 23, 2020
AbCellera
|
Series A | $75M | Artificial Intelligence | Yes |
Feb 25, 2020
MycoWorks
|
Series A | $17M | Advanced Materials | Yes |
Dec 1, 2019
Alchemab Therapeutics
|
Seed | — | Biotechnology | Yes |